Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

GRCE

$2.26+5.61%website ↗

Grace Therapeutics, Inc.

Market Cap
$45M
Sector
Materials
Industry
Pharmaceuticals
Beta
0.39
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.9x
buying
Congress
—
recent trades
Short Volume
50%
W/W +10.1pp

Market & Alt Data

News
10
recent articles
Activist
13D
Acasti
Analyst Consensus
Strong Buy
8 analysts
Velocity Score
24.85x
Current Rate (90d)
1409.30/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-09-092026-09-10Kohli PrashantDirector & Chief Executive OfficerPurchase100.0K$2.14$214K121.4KView
2026-09-092026-09-10Opaleye Management Inc.10% OwnerPurchase5,836$2.09$12K2.78MView
2026-09-082026-09-10Opaleye Management Inc.10% OwnerPurchase9,393$2.10$20K2.77MView
2026-08-142026-08-19Opaleye Management Inc.10% OwnerPurchase11.6K$2.09$24K2.76MView

Recent News

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Yahoo · 2026-09-03
Grace Therapeutics Files Prospectus For Offering 4.762M Common Shares On Behalf Of Selling Shareholders
Benzinga · 2026-08-24
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
Yahoo · 2026-08-13
Grace Therapeutics Q1 EPS $(0.91) Misses $(0.18) Estimate
Benzinga · 2026-08-13

Informational purposes only, not investment advice.

Grace Therapeutics Announces $10 Million Private Placement
Yahoo Finance · 2026-08-05
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
Yahoo Finance · 2026-07-28
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
Yahoo Finance · 2026-06-18
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Yahoo Finance · 2026-04-23
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Yahoo Finance · 2026-04-14
We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate
Yahoo Finance · 2026-04-04

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 3
1 active trial